DFCI/ALL Logo

Coordinating Center:

 Dana-Farber

Participating Centers:

Beth Israel Deconess Medical Center •  Cancer Care Manitoba •  Centre Hospitalier Universitaire de Quebec •  Columbia Presbyterian MC •  Cross Cancer Institute •  Fairfax/Inova •  Hospital Maisonneuve-Rosemont •  Hospital Sainte Justine •  LDS Hospital •  London Health Science Center •  Maine Children's Cancer Program •  McMaster University MC •  Montefiore/Albert Einstein •  Ohio State Univ MC •  Rhode Island Hospital (Hasbro)  •  Roswell Park  •  Rutgers Cancer Institute of NJ  •  Queen Elizabeth II •  Queen's Univ/Kingston General Hospital •  San Jorge Children's Hospital •  Saskatchewan CancerAgency •  Tom Baker Cancer Center •  Tulane University Hospital and Clinic •  Univ. of Rochester MC •  Vancouver General Hospital

About the DFCI/ALL Consortium

Since 1973, we have investigated children diagnosed with ALL in a consecutive series of clinical trials based at Dana-Farber Cancer Institute.  The DFCI/ALL Consortium began in 1981 and gradually grew in the 1980s and 1990s when members of the Dana-Farber Cancer Institute/Children's Hospital staff became Division Chiefs in Pediatric Hematology/Oncology at the University of Puerto Rico in San Juan, University of Rochester Medical Center. A traditional referral source, the Maine Children's Cancer program, joined the Consortium at its inception.  Investigators at the three Canadian centers all joined selectively (between 1985 and 1993) based on their desire to participate in the clinical trials and related research programs. In 2003, Tulane University Hospital and Clinic also joined the Consortium.  We now have a group of nine collaborating institutions who collectively accrue newly diagnosed pediatric patients for treatment.  In 2001, research investigating adult ALL began within the Consortium.

The clinical and administrative structure of the Consortium is the responsibility of the Principal Investigator (Dr. Stephen Sallan) who is supported in these efforts by (Dr. Richard Gelber) from the Department of Biostatistical Science at the Dana-Farber Cancer Institute, as well as clinical research support personnel in the Dana-Farber Cancer Institute Quality Assurance Office for Clinical Trials.

Members of the DFCI/ALL Consortium

Coordinating Center:


Dana-Farber Cancer Institute
Since 1972.

Current Participating Centers:


Columbia Presbyterian Medical Center
Since 2002.


Hospital Sainte Justine
Since 1987.


Centre Hospitalier Universitaire de Quebec
Since 1991.


Fairfax/Inova
Since 2008.


McMaster University MC
Since 1985.


Montefiore/Albert Einstein
Since 2008.


Rhode Island Hospital (Hasbro)
Since 2007.


Roswell Park
Since 2017.


Rutgers Cancer Institute of NJ
Since 2019.


San Jorge Children's Hospital
Since 1991.


Univ. of Rochester MC
Since 1981.



Centers in Follow-Up Only as of 2018:


Vancouver General Hospital

Queen Elizabeth II

Tom Baker Cancer Center

London Health Science Center

Hospital Maisonneuve-Rosemont

Saskatchewan Cancer Agency

Cross Center Institute

Cancer Care Manitoba

Queens University/Kingston Hospital

Tulane

Ohio State University Med Ctr

Maine Children's Cancer Program

LDS Hospital

Eastern Maine Medical Center

Mt. Sinai Medical Center

Ochsner Clinic

University of Mass Medical Center
Back Print